LC
GH icon

Lindbrook Capital’s Guardant Health GH Stock Holding History

Lindbrook Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$23.3K Buy
546
+5
+0.9% +$216 ﹤0.01% 1290
2024
Q4 		$16.5K Buy
541
+61
+13% +$1.72K ﹤0.01% 1397
2024
Q3 		$11K Sell
480
-156
-25% -$4.42K ﹤0.01% 1625
2024
Q2 		$18.4K Buy
636
+522
+458% +$12.2K ﹤0.01% 1292
2024
Q1 		$2.35K Sell
114
-115
-50% -$2.46K ﹤0.01% 2184
2023
Q4 		$6.19K Sell
229
-379
-62% -$9.94K ﹤0.01% 1769
2023
Q3 		$18K Buy
608
+171
+39% +$6.01K ﹤0.01% 1106
2023
Q2 		$15.6K Buy
437
+169
+63% +$4.85K ﹤0.01% 1217
2023
Q1 		$6.28K Buy
268
+174
+185% +$4.97K ﹤0.01% 1749
2022
Q4 		$2.56K Sell
94
-192
-67% -$8.79K ﹤0.01% 2122
2022
Q3 		$15K Buy
286
+224
+361% +$11.5K ﹤0.01% 1130
2022
Q2 		$3K Buy
+62
New +$3.07K ﹤0.01% 1782
2022
Q1 		– Sell
-4
Closed -$274 – 2526
2021
Q4 		$0 Sell
4
-7
-64% -$724 ﹤0.01% 2126
2021
Q3 		$1K Buy
11
+6
+120% +$713 ﹤0.01% 1722
2021
Q2 		$1K Buy
+5
New +$673 ﹤0.01% 1763
2019
Q2 		– Sell
-100
Closed -$7K – 1441
2019
Q1 		$7K Buy
+100
New +$5.54K ﹤0.01% 990

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lindbrook Capital's GH Position: Q1 2025 in Review

Lindbrook Capital increased its Guardant Health (GH) stake by 0.92% in Q1 2025, buying an estimated $216 and bringing the position to 546 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

Lindbrook Capital first reported a position in GH in Q1 2019 and has held it in 16 quarters since. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.

  • Lindbrook Capital held 546 shares of Guardant Health worth $23.3K as of Q1 2025.
  • Lindbrook Capital bought 5 Guardant Health shares in Q1 2025, an estimated $216.
  • Guardant Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1290 holding.
  • Lindbrook Capital first reported a position in Guardant Health in Q1 2019 and has held it in 16 quarters since.
  • 342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.